Target intelligence / Profile preview

Spleen and kidney

Molecular classification
None (Anatomical organs/Pathological syndrome)
01

Overview

"Spleen and kidney" does not identify a single molecular target, such as a protein, receptor, or enzyme, but instead refers to a pair of anatomical organs or a clinical syndrome in Traditional Chinese Medicine (TCM). In pharmacology, the term is most frequently encountered in the context of "Spleen and Kidney Deficiency," a pathological pattern used in TCM to describe the progression of chronic kidney disease and diabetic nephropathy, which is treated with multi-component herbal formulas designed to regulate immune and metabolic pathways [10, 15]. In veterinary medicine and aquaculture, the phrase is associated with the "Infectious Spleen and Kidney Necrosis Virus" (ISKNV), a significant double-stranded DNA virus that causes severe organ damage and high mortality in various fish species [1, 5, 17]. Furthermore, these organs are often described as "target organs" for the expression of inducible nitric oxide synthase (iNOS) during conditions like endotoxic shock [2]. Because the provided name refers to an organ pair or a complex disease state rather than a discrete biological molecule, it is not considered a valid canonical therapeutic target in a biotech or drug development context.

Other names
Spleen and kidney deficiency syndromeInfectious spleen and kidney necrosis virus (ISKNV)Spleen and kidney qi deficiencyJianpi-YishenSpleen-kidney-care
02

Mechanism of action

Traditional Chinese Medicine (TCM) formulas target multiple proteins (e.g., AKT1, TNF) to 'tonify' these organs and reduce inflammation; in viral contexts, refers to the pathogenesis of systemic organ failure [5, 10, 13].

03

Biological functions

Immune responseMetabolic regulationBlood filtration
04

Disease associations

Chronic kidney diseaseDiabetic nephropathyInfectious spleen and kidney necrosis (aquaculture)Endotoxic shock
05

Safety considerations

Lack of molecular specificityPotential herbal-drug interactionsNon-target for specific molecular drug developmentHigh mortality rates in aquaculture (for the virus)
06

Interacting drugs

Jianpi-Yishen formula (JPYS)

5 more in the full profile.

07

Biomarkers

Serum creatinineBlood urea nitrogen (BUN)Urinary albumin excretion rate (UAER)Malondialdehyde (MDA) (ISKNV infection)Reactive oxygen species (ROS) (ISKNV infection)

Beyond the preview

Go deeper on Spleen and kidney.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Spleen and kidney.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call